Status:

COMPLETED

PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide

Lead Sponsor:

M.D. Anderson Cancer Center

Conditions:

Gastrointestinal Disease

Esophageal Cancer

Eligibility:

All Genders

Phase:

PHASE2

Brief Summary

The goal of this clinical research study is to use a new breathing test that measures the amount of nitric oxide (NO) you exhale. Researchers want to compare your "NO" levels to the amount of inflamma...

Detailed Description

Lung Cancer Cohort: NO Breathing Test: If you agree to take part in this study, you will have a breathing test performed before starting radiation therapy, weekly during radiation therapy and, about...

Eligibility Criteria

Inclusion

  • Patients with pathologic diagnosis of esophagus cancer.
  • For the cohort 2, patients with the pathological diagnosis of lung cancer.
  • For the cohort 3, patients with any pathological diagnosis of a thoracic malignancy.
  • Patients must sign informed consent.
  • Patients who will receive concurrent chemotherapy and radiation therapy will be undergoing PET-scan for restaging between 25 and 75 days after radio therapy.
  • For Lung Cohort, patients who will receive concurrent chemotherapy and radiation therapy or greater or equal to 3 weeks of radiation therapy alone.
  • For the Lung Cohort, participation in a PET-scan for restaging between 40-50 days after radiotherapy is required. 10 patients will receive a second PET-scan within 2-7 days as a test for reproducibility.

Exclusion

  • Significant pleural effusion as evaluated by the attending Radiation Oncologist is excluded.
  • Patients who received thoracic radiotherapy prior to the study.

Key Trial Info

Start Date :

March 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2014

Estimated Enrollment :

163 Patients enrolled

Trial Details

Trial ID

NCT00867477

Start Date

March 1 2009

End Date

August 1 2014

Last Update

August 28 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UT MD Anderson Cancer Center

Houston, Texas, United States, 77030